554 related articles for article (PubMed ID: 32341463)
21. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.
Harris ML; Darrah E; Lam GK; Bartlett SJ; Giles JT; Grant AV; Gao P; Scott WW; El-Gabalawy H; Casciola-Rosen L; Barnes KC; Bathon JM; Rosen A
Arthritis Rheum; 2008 Jul; 58(7):1958-67. PubMed ID: 18576335
[TBL] [Abstract][Full Text] [Related]
22. Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases.
Holmes CL; Shim D; Kernien J; Johnson CJ; Nett JE; Shelef MA
J Immunol Res; 2019; 2019():2160192. PubMed ID: 30993117
[TBL] [Abstract][Full Text] [Related]
23. Rheumatoid arthritis and citrullination.
Darrah E; Andrade F
Curr Opin Rheumatol; 2018 Jan; 30(1):72-78. PubMed ID: 28937414
[TBL] [Abstract][Full Text] [Related]
24. Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses.
Mergaert AM; Denny MF; Kingstad-Bakke B; Bawadekar M; Bashar SJ; Warner TF; Suresh M; Shelef MA
J Immunol Res; 2022; 2022():5258221. PubMed ID: 35083342
[TBL] [Abstract][Full Text] [Related]
25. Peptidylarginine Deiminase 2 Gene Polymorphisms in Subjects with Periodontitis Predispose to Rheumatoid Arthritis.
Massarenti L; Enevold C; Damgaard D; Hansen PR; Frisch M; Ødum N; Jacobsen S; Nielsen CH
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076933
[TBL] [Abstract][Full Text] [Related]
26. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types.
Arnoux F; Mariot C; Peen E; Lambert NC; Balandraud N; Roudier J; Auger I
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10169-E10177. PubMed ID: 29109281
[TBL] [Abstract][Full Text] [Related]
27. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
[TBL] [Abstract][Full Text] [Related]
28. Insights into the study and origin of the citrullinome in rheumatoid arthritis.
Fert-Bober J; Darrah E; Andrade F
Immunol Rev; 2020 Mar; 294(1):133-147. PubMed ID: 31876028
[TBL] [Abstract][Full Text] [Related]
29. Bacterial citrullinated epitopes generated by
Jenning M; Marklein B; Ytterberg J; Zubarev RA; Joshua V; van Schaardenburg D; van de Stadt L; Catrina AI; Nonhoff U; Häupl T; Konthur Z; Burmester GR; Skriner K
Ann Rheum Dis; 2020 Sep; 79(9):1194-1202. PubMed ID: 32532752
[TBL] [Abstract][Full Text] [Related]
30. Citrullination by peptidylarginine deiminase in rheumatoid arthritis.
Suzuki A; Yamada R; Yamamoto K
Ann N Y Acad Sci; 2007 Jun; 1108():323-39. PubMed ID: 17893996
[TBL] [Abstract][Full Text] [Related]
31. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14
Okamato Y; Ghosh T; Okamoto T; Schuyler RP; Seifert J; Charry LL; Visser A; Feser M; Fleischer C; Pedrick C; August J; Moss L; Bemis EA; Norris JM; Kuhn KA; Demoruelle MK; Deane KD; Ghosh D; Holers VM; Hsieh EWY
J Autoimmun; 2021 Feb; 117():102581. PubMed ID: 33310262
[TBL] [Abstract][Full Text] [Related]
32. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
Damgaard D; Senolt L; Nielsen CH
Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
[TBL] [Abstract][Full Text] [Related]
34. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis.
Engström M; Eriksson K; Lee L; Hermansson M; Johansson A; Nicholas AP; Gerasimcik N; Lundberg K; Klareskog L; Catrina AI; Yucel-Lindberg T
J Transl Med; 2018 Jul; 16(1):214. PubMed ID: 30064459
[TBL] [Abstract][Full Text] [Related]
35. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
36. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
37. Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis.
El Shikh MEM; El Sayed R; Nerviani A; Goldmann K; John CR; Hands R; Fossati-Jimack L; Lewis MJ; Pitzalis C
J Autoimmun; 2019 Dec; 105():102297. PubMed ID: 31277965
[TBL] [Abstract][Full Text] [Related]
38. Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity.
Darrah E; Giles JT; Ols ML; Bull HG; Andrade F; Rosen A
Sci Transl Med; 2013 May; 5(186):186ra65. PubMed ID: 23698378
[TBL] [Abstract][Full Text] [Related]
39. Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.
Shi J; Darrah E; Sims GP; Mustelin T; Sampson K; Konig MF; Bingham CO; Rosen A; Andrade F
Ann Rheum Dis; 2018 Jan; 77(1):141-148. PubMed ID: 29070531
[TBL] [Abstract][Full Text] [Related]
40. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]